Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1147 ARTÍCULOS , VIENDO DEL 91 AL 105

The organellar peptidasome, PreP: a journey from Arabidopsis to Alzheimer's disease

Glaser E, Alikhani N.

Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1076-80. doi: 10.1016/j.bbabio.2009.12.016. Epub 2009 Dec 28.

Methods and models in neurodegenerative and systemic protein aggregation diseases

Brorsson AC, Kumita JR, MacLeod I, Bolognesi B, Speretta E, Luheshi LM, Knowles TP, Dobson CM, Crowther DC.

Front Biosci (Landmark Ed). 2010 Jan 1;15(1):373-96. doi: 10.2741/3626.

Chemoattractants and receptors in Alzheimer's disease

Ruan L, Kong Y, Wang JM, Le Y.

Front Biosci (Schol Ed). 2010 Jan 1;2(2):504-14. doi: 10.2741/s81.

'Current Alzheimer research' helps accelerate the progress of the field

Lahiri DK.

Curr Alzheimer Res. 2010 Feb;7(1):1-2. doi: 10.2174/156720510790274419.

Inhibition of double-stranded RNA-dependent protein kinase strongly decreases cytokine production and release in peripheral blood mononuclear cells from patients with Alzheimer's disease

Couturier J, Page G, Morel M, Gontier C, Claude J, Pontcharraud R, Fauconneau B, Paccalin M.

J Alzheimers Dis. 2010;21(4):1217-31. doi: 10.3233/jad-2010-100258.

Modified immunotherapies against Alzheimer's disease: toward safer and effective amyloid clearance

Wang YJ, Zhou HD, Zhou XF.

J Alzheimers Dis. 2010;21(4):1065-75. doi: 10.3233/jad-2010-100195.

High resolution imaging of the medial temporal lobe in Alzheimer's disease and dementia with Lewy bodies

Firbank MJ, Blamire AM, Teodorczuk A, Teper E, Burton EJ, Mitra D, O'Brien JT.

J Alzheimers Dis. 2010;21(4):1129-40. doi: 10.3233/jad-2010-100138.

Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment

Baldeiras I, Santana I, Proença MT, Garrucho MH, Pascoal R, Rodrigues A, Duro D, Oliveira CR.

J Alzheimers Dis. 2010;21(4):1165-77. doi: 10.3233/jad-2010-091723.

Lost and found: bespoke memory testing for Alzheimer's disease and semantic dementia

Pengas G, Patterson K, Arnold RJ, Bird CM, Burgess N, Nestor PJ.

J Alzheimers Dis. 2010;21(4):1347-65. doi: 10.3233/jad-2010-100654.

Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?

Trepanier CH, Milgram NW.

J Alzheimers Dis. 2010;21(4):1089-99. doi: 10.3233/jad-2010-090667.

Molecular regulations induced by acrolein in neuroblastoma SK-N-SH cells: relevance to Alzheimer's disease

Dang TN, Arseneault M, Zarkovic N, Waeg G, Ramassamy C.

J Alzheimers Dis. 2010;21(4):1197-216. doi: 10.3233/jad-2010-100417.

Dementia

Warner JP, Butler R, Gupta S.

BMJ Clin Evid. 2010 Apr 8;2010:1001.

Amyloid β oligomers decrease hippocampal spontaneous network activity in an age-dependent manner

Balleza-Tapia H, Huanosta-Gutiérrez A, Márquez-Ramos A, Arias N, Peña F.

Curr Alzheimer Res. 2010 Aug;7(5):453-62. doi: 10.2174/156720510791383859.

Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer's disease

Fu AL, Zhou CY, Chen X.

Neuropharmacology. 2010 Mar-Apr;58(4-5):722-9. doi: 10.1016/j.neuropharm.2009.12.020. Epub 2010 Jan 5.

Naturally occurring phytochemicals for the prevention of Alzheimer's disease

Kim J, Lee HJ, Lee KW.

J Neurochem. 2010 Mar;112(6):1415-30. doi: 10.1111/j.1471-4159.2009.06562.x. Epub 2009 Dec 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias